The rate of survival after diagnosis was significantly lower for patients with advanced clinical stage, rural residence, Mucinous cell carcinoma, and elevated CEA level, indicating the critical role of early detection and timely treatment initiation in improving CRC survival and quality of life. This evidence concerns the gene CEACAM5 and colorectal carcinoma.